This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
home:othertreatments:pain_medication [02.07.2019] – [Pain medications and muscle relaxants] sallieq | home:othertreatments:pain_medication [02.23.2019] – [Types of pain medications] sallieq | ||
---|---|---|---|
Line 32: | Line 32: | ||
* **morphine** – avoid if possible - shown to be immunosuppressive in a study(({{pubmed> | * **morphine** – avoid if possible - shown to be immunosuppressive in a study(({{pubmed> | ||
* **naltrexone** – an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. Naltrexone would certainly appear to affect the ability of the MP to return the human immune system to full function again. Lymphocytes express opioid receptors, probably for a good reason. Even though that reason is not fully understood, it is not a good idea to block those opioid receptors (with naltrexone) if one expects to be able to return your immune system to normal. | * **naltrexone** – an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. Naltrexone would certainly appear to affect the ability of the MP to return the human immune system to full function again. Lymphocytes express opioid receptors, probably for a good reason. Even though that reason is not fully understood, it is not a good idea to block those opioid receptors (with naltrexone) if one expects to be able to return your immune system to normal. | ||
+ | |||
+ | |||
+ | Ultra-low dose naltrexone enhances cannabinoid-induced antinociception. | ||
+ | |||
+ | Surprisingly, | ||
< | < |